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Background: Prostaglandins (PGs) play pathogenic and pro-
tective roles in inflammatory diseases. The novel concept of 
PGs as immune modulators is being documented by several 
investigators. By establishing an in vitro experimental model 
containing human follicular dendritic cell-like cells, HK cells, 
we reported that HK cells produce prostaglandin E2 (PGE2) 
and prostaglandin I2 (PGI2) and that these PGs regulate bio-
logical functions of T and B cells. Methods: To investigate the 
respective contribution of cyclooxygenase-1 (COX-1) and 
COX-2 to PGE2 and PGI2 production in HK cells, we per-
formed siRNA technology to knock down COX enzymes and 
examined the effect on PG production. Results: Both PGE2 
and PGI2 productions were almost completely inhibited by 
the depletion of COX-2. In contrast, COX-1 knockdown did 
not significantly affect PG production induced by lip-
opolysaccharide (LPS). Conclusion: The current results sug-
gest that mPGES-1 and PGIS are coupled with COX-2 but 
not with COX-1 in human follicular dendritic cell (FDC) and 
may help understand the potential effects of selective COX 
inhibitors on the humoral immunity.
[Immune Network 2011;11(6):364-367]
INTRODUCTION
Prostanoids are small lipid molecules, playing important roles 
in various physiological and pathological processes, such as 
kidney function, vasodilation, platelet aggregation, and cancer 
progress (1). Prostanoids are derived from membrane glycer-
ophospholipids in response to inflammatory stimuli via three 
sequential enzymatic reactions. The first reaction is mediated 
by phospholipase A2, which liberates arachidonic acids from 
membrane phospholipids (2). The arachidonic acids are sub-
ject to the second reactions and converted to prostaglandin 
(PG) G2 and then PGH 2 by cyclooxygenases (COXs), COX-1 
or COX-2. The last steps of prostanoid production depend on 
tissue- and cell-specific terminal synthases. PGH2 are metabo-
lized  to  PGE2,  PGI2,  PGD2,  PGF2α,  and  thromboxane  A2 
(TXA2) by respective actions of PGE2 synthase (PGES), PGI2 
synthase  (PGIS),  PGD2  synthase  (PGDS),  PGF2 s y n t h a s e  
(PGFS),  and  thromboxane  synthase  (3).  In  particular,  PGE2 
is catalyzed by three different PGESs, cytosolic PGES (cPGES) 
and  two  membrane-bound  PGESs,  mPGES-1  and  mPGES-2 
(4). The expression of cPGES and mPGES-2 are constitutive, 
while  mPGES-1  is  induced  during  inflammation.
    In addition to the well-known roles of prostanoids as in-
flammatory and vascular mediators (5,6), they are recognized 
as  important  immune  modulators  (7-9).  For  instance,  PGE2 
exhibits  immunostimulatory  as  well  as  immunosuppressive 
activities depending on its concentrations. PGE2 inhibits acti-
vation, proliferation, and differentiation of T cells at micro-
molar  concentrations,  whereas  it  potentiates  Th1  and  Th17 
differentiation and proliferation of T cells at nanomolar con-
centrations  (10). 
  U s i n g  a n  in vitro model of germinal center reactions that 
contains  human  follicular  dendritic  cell  (FDC)-like  cells  HK 
(11), we have demonstrated that both FDC and HK cells ex-
press PGI2 synthase (12), PGI2  production  is  not controlled 
by the induction of PGIS but by COX-2 (13), HK cells secrete 
PGI2 and PGE 2 but not TXA2 (14), PGs produced by HK cells Prostaglandin Production Depends on COX-2 in Human FDC
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inhibit proliferation and apoptosis T cells (14), T cells control 
PG production from HK cells via IL-4-Janus kinase 1 (JAK1)- 
Signal  transducer  and  activator  of  transcription  6  (STAT6)- 
COX-2  pathway  (15),  and  PGI2  and  its  analogues  enhance 
C D 8 6  e x p r e s s i o n  o n  t h e  s u r f a c e  o f  a c t i v a t e d  B  c e l l s  ( 1 6 ) .  
These results support the emerging concept of PGs as critical 
immune  modulators.
    In this study, we investigated the relative contribution of 
COX-1 and COX-2 to PGI2 and PGE 2 synthesis in HK cells. 
Several studies demonstrated the coupling between COXs and 
terminal  prostanoid  synthases.  However,  most  studies  were 
performed using murine cells (2). The current results suggest 
that mPGES-1 and PGIS are coupled with COX-2 but not with 
COX-1 in human FDC and imply that chronic administration 
of selective COX-2 inhibitors might disturb the normal humor-
al immune responses taking place in the culminating site of 
germinal  centers.
MATERIALS AND METHODS
Culture of HK cells
HK cells are primary cells obtained from human tonsils and 
used until they display degenerate features in culture. They 
are prepared as described by Kim et al. (17) and maintained 
in  RPMI-1640  (Irvine  Scientific,  Santa  Ana,  CA)  containing 
10% fetal calf serum (Hyclone, Logan, UT), 2 mM L-glutamine 
(Invitrogen, Carlsbad, CA), 100 U/ml penicillin G (Sigma- Al-
drich, St. Louis, MO), and 100μg/ml streptomycin (Invitro-
gen). Lipopolysaccharide (LPS)  was  purchased from  Sigma- 
Aldrich.
Immunoblotting
The whole cell lysates of HK cells were subject to immuno-
blotting  as  previously  described  (18).  The  protein  concen-
trations of the each fraction were assayed with a bicinchonic 
a c i d  ( B C A )  a s s a y .  U s e d  a n t i b o d i e s  w e r e  a g a i n s t  C O X - 1 ,  
COX-2 (Cayman Chemical, Ann Arbor, MI), β-actin (Sigma- 
Aldrich),  and  horseradish  peroxidase  (HRP)-conjugated  an-
ti-mouse  IgG  (Jackson  Immunoresearch,  West  Grove,  PA). 
The membranes were incubated with SuperSignal West Pico 
Chemiluminescent  Substrate  (Pierce,  Rockford,  IL)  and  ex-
posed  to  X-ray  films.
siRNA transfection
The siRNA duplexes used (Ambion Inc, Austin, TX) were con-
structed  with  the  following  target  sequences.  Control 
(Neg-siRNA#2,  sequence  not  disclosed  by  Ambion);  COX-1, 
sense (5'-GCUCUUUAAGGAUGGGAAATT-3'), antisense (5'-U 
UUCCCAUCCUUAAAGAGCCG-3'); COX-2, sense (5'-CCA CC 
CAUGUCAAAACCGATT-3'),  antisense  (5'-UCG  GUUUUGA 
CAUGGGUGGGA-3').  HK  cells  were  cultured  to  50∼60% 
confluence in 100 mm plates. For each plate, 40 nM of each 
siRNA and 24μl Lipofectamine
TM (Invitrogen) were separately 
diluted  in  400μl  serum-free  medium  without  antibiotics, 
mixed together, and incubated at RT for 45 min. The plates 
were then washed with serum-free medium, added with 5 ml 
serum-free medium, and then with the diluted solutions. The 
plates were incubated at 37
oC for 8 h, followed by the addi-
tion of a growth medium containing 10% serum. After 48 h 
of additional incubation, cells were used for experiments. The 
degree  of  gene-silencing  was  assayed  by  immunoblotting.
Enzyme immunoassay to measure prostaglandins
HK  cells  were  cultured  with  LPS  for  48  h  to  harvest  the 
supernatants. The amounts of PGE2 and 6-keto-PGF1α, stable 
metabolite of PGI2, were measured using enzyme immuno-
assay  (EIA)  kits  as  described  previously  (14).  PG  concen-
tration was normalized to total cellular protein and expressed 
a s  n g / m g  p r o t e i n .
Statistical analysis
Statistical analysis and graphic presentation were carried out 
with GraphPad Prism 4.0. The statistical significance of differ-
ences was determined by Student’s t-test; p＜0.05 was con-
sidered  significant.
RESULTS
To investigate the relative contribution of COX-1 and COX-2 
to the production of PGE 2 and PGI 2, we carried out siRN A 
technology to knock down COX-1 and COX-2 proteins in HK 
cells. HK cells were transfected with siRNA duplexes specific 
to COX-1 and COX-2 and cultured for 48 h, followed by fur-
ther cultures in the presence or absence of LPS. The silencing 
of target proteins was demonstrated by immunoblotting. As 
shown in Fig. 1, COX-2 protein levels were up-regulated by 
LPS stimulation in control siRNA-transfected HK cells, where-
as COX-1 levels were unaffected by LPS treatment. Transfec-
tion with COX-1-specific siRNA resulted in significant reduc-
t i o n  o f  C O X - 1  p r o t e i n  l e v e l s  r e g a r d l e s s  o f  L P S  s t i m u l a t i o n .  
Interestingly, LPS-induced COX-2 levels in COX-1 siRNA-trans-Prostaglandin Production Depends on COX-2 in Human FDC
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Figure 1. COX-1 and COX-2 proteins were markedly depleted in HK
cells by siRNA technology. Control, COX-1, or COX-2 siRNA-tran-
sfected HK cells (1×105 cells) were cultured for 48 h, followed by
further incubation in the presence or absence of LPS (1μg/ml) for 8
h. The depletion degree of target proteins was evaluated by im-
munoblotting.  β-actin was used to demonstrate equal loading of 
lysates. The results were reproducible in three independent ex-
periments.
Figure 2. Depletion of COX-2 but not COX-1 prevents LPS-induced 
production of PGE2 and PGI2. Control, COX-1, or COX-2 siRNA-tra-
nsfected HK cells (1×10
5 cells) were cultured for 48 h, followed by 
further incubation in the presence or absence of LPS (1μg/ml) for 
another 48 h. The amounts of PGE2 (A) and 6-keto-PGF1α (B) in the 
culture supernatants were measured by EIA and normalized by protein
concentration in each well. Data are presented as means±standard
error of the mean (SEM) of duplicates. Representative results of three
reproducible experiments. Asterisks indicate significant differences (*p
＜0.05, **p＜0.01). NS, non-significant.
fected cells were markedly higher compared to control cells. 
Transfection  with  COX-2-specific  siRNA  almost  completely 
prevented induction of COX-2 proteins that was triggered by 
LPS.  COX-2  silencing  did  not  significantly  affect  COX-1  ex-
pression levels. These results indicate that COX-1 and COX-2 
proteins  were  successfully  knocked  down  in  HK  cells  by 
siRNA  duplexes.  We  next  measured  the  concentrations  of 
PGE2 and 6-keto-PGF1α in the culture supernatants after in-
cubation of siRNA-transfected cells in the presence or absence 
of  LPS  for  48  h.  6-keto-PGF1α  is  the  hydrolysis  product  of 
unstable PGI2. PGE2 and 6-keto-PGF1α concentrations in con-
trol cells were increased 4- and 5-folds, respectively, by LPS 
stimulation (Fig. 2). Similar levels of enhancement were ob-
tained  in  COX-1  siRNA-transfected  cells.  In  contrast,  COX-2 
silencing almost completely prevented the PG production to 
background levels. We observed that knock down of COX-1 
resulted in a significant increase of PGE2 but not PGI2 without 
LPS stimulation (Fig. 2A). Whether this result reflects a prefer-
ential coupling of COX-2 with PGES over PGIS is currently 
unclear.  Based  upon  these  results,  we  conclude  that  PGE2 
and  PGI2  production  is  coupled  with  COX-2  but  not  with 
COX-1  in  HK  cells. 
DISCUSSION
    In this study, we demonstrate that LPS stimulates FDC-like 
cells to produce PGE2 and PGI2, which depends on the pres-
ence of COX-2. Our results imply that FDC is a physiologic 
source of PG during inflammatory immune responses to bac-
terial infection. PGs secreted from FDC may exert regulatory 
roles in the various processes taking place in germinal centers 
of  the  secondary  lymphoid  tissues  (7-9).
  P G E 2 and PGI2 are biosynthesized by mPGES-1 and PGIS. 
In  line  with  the  current  data,  we  previously  provided  evi-
dence that COX-2 and mPGES-1 are functionally associated. 
COX-2 and mPGES-1 mRNA and proteins were increased by 
LPS treatment, which was inhibited by IL-4 (14,15). mPGES-1 
induction  by  LPS  stimulation  occurred  following  COX-2  in-
duction in HK cells (14). This coordinated kinetics of COX-2 
and mPGES-1 induction may contribute to the efficient pro-
duction of PGE2. In contrast, PGIS is constitutive in HK cells 
(13,14). Therefore, the PGI2 production in HK cells may de-
pend on the substrate supply for downstream PGIS from up-
stream COX-2, suggesting the coupling of COX-2 with PGIS. 
This interpretation is compatible with the general belief that 
inducible COX-2 is required for delayed PG synthesis whereas Prostaglandin Production Depends on COX-2 in Human FDC
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constitutive COX-1 is necessary for immediate PG production 
after  inflammatory  stimulation  (2).  Further  investigation  is 
necessary to determine whether the functional association of 
COX-2 with mPGES-1 and PGIS results from physical coupling 
of  these  enzymes.  Confocal  microscopy  may  be  a  useful 
method to study their possible colocalization and subcellular 
localization. However, the coupling between COX-2 and PGIS 
is not absolute and appears to vary depending on cell types. 
Different from HK cells, Bolego et al. reported that PGI2 pro-
duction is coupled with COX-1 but not with COX-2 in human 
endothelial cells (19). PGIS is constitutively expressed in hu-
man endothelial cells (20). Furthermore, stimulus types and 
the degree of substrate abundance seem to affect the func-
tional  coupling  between  COX  and  PGIS  or  mPGES-1.
    Considering the accumulating reports on the side effects of 
selective COX inhibitors (21), the current data may help un-
derstand the potential effects of selective COX inhibitors on 
the  humoral  immunity. 
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